Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction …
M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2013 - Springer
Purpose To apply physiologically-based pharmacokinetic (PBPK) modeling to investigate
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction …
M Gertz, C Cartwright, M Hobbs… - Pharmaceutical …, 2013 - search.ebscohost.com
Purpose: To apply physiologically-based pharmacokinetic (PBPK) modeling to investigate
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction …
M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2013 - infona.pl
Purpose To apply physiologically-based pharmacokinetic (PBPK) modeling to investigate
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction …
M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2013 - search.proquest.com
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters:
Application of PBPK Modeling in the As Page 1 RESEARCH PAPER Cyclosporine Inhibition of …
Application of PBPK Modeling in the As Page 1 RESEARCH PAPER Cyclosporine Inhibition of …
[引用][C] Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug …
M GERTZ, CM CARTWRIGHT… - Pharmaceutical …, 2013 - pascal-francis.inist.fr
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters:
Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential CNRS Inist …
Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential CNRS Inist …
Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction …
M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2013 - pubmed.ncbi.nlm.nih.gov
Purpose To apply physiologically-based pharmacokinetic (PBPK) modeling to investigate
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction …
M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2012 - europepmc.org
Purpose To apply physiologically-based pharmacokinetic (PBPK) modeling to investigate
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
[引用][C] Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug …
M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2012 - cir.nii.ac.jp
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters:
Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential | CiNii …
Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential | CiNii …
Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: Application of PBPK Modeling in the assessment of drug-drug interaction …
M Gertz, CM Cartwright, MJ Hobbs… - Pharmaceutical …, 2013 - research.manchester.ac.uk
Purpose: To apply physiologically-based pharmacokinetic (PBPK) modeling to investigate
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
the consequences of reduction in activity of hepatic and intestinal uptake and efflux …
[引用][C] Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: Application of PBPK modeling in the assessment of drug‐drug …
M Gertz - Pharm Res - cir.nii.ac.jp
Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters:
Application of PBPK modeling in the assessment of drug‐drug interaction potential | CiNii …
Application of PBPK modeling in the assessment of drug‐drug interaction potential | CiNii …